All filters
Slidesets
Two Drug Regimens - Pros and Cons | Jürgen Rockstroh, MD
Presented at:
Russian HIV Clinical Forum 2018
Slidesets
Optimal use on integrase inhibitors in women and special populations (such as Injection drug users, HCV co-infected) | Elena Stepanova, MD
Presented at:
Russian HIV Clinical Forum 2018
Slidesets
Optimal use of integrase inhibitors in routine clinical practice | Anton Pozniak, MD, FRCP
Presented at:
Russian HIV Clinical Forum 2018
Meeting
European HIV Clinical Forum 2018
Slidesets
Longer duration of virological suppression and a fully active companion drug ensure a high rate of virological control in HIV-1 infected patients switching to a dual therapy containing integrase inhibitors- Daniele Armenia
Presented at:
European HIV Clinical Forum 2018
Slidesets
Integrase inhibitors in specific populations- Women and those aging with HIV- Sharon Walmsley, FRCPC, MD, MSC
Presented at:
European HIV Clinical Forum 2018
Slidesets
Long-acting ARV for treatment & prevention: clinical considerations- Laura Waters, MD, FRCP
Presented at:
European HIV Clinical Forum 2018
Slidesets
Pharmacologic characteristics and delivery options for integrase inhibitors- Courtney Fletcher, PharmD
Presented at:
European HIV Clinical Forum 2018
Slidesets
Intergrase inhibitors- What's new?-Margaret Johnson, MD
Presented at:
European HIV Clinical Forum 2018
Slidesets
Resistance to integrase inhibitors- What clinicians need to know- Roger Paredes, MD, PhD
Presented at:
European HIV Clinical Forum 2018
Slidesets
Reduced drug regimens- What are the data?- Jose Arribas, MD
Presented at:
European HIV Clinical Forum 2018
Slidesets
Switching antiretroviral therapy to safer strategies based on intergrase inhibitors- Pedro Cahn, MD, PhD
Presented at:
European HIV Clinical Forum 2018
Slidesets
Immune modulatory effects of vaginal microbiota organic acid metabolites on lower female reproductive tract epithelial cells- Gilda Tachedjian
Presented at:
International Workshop on HIV Transmission 2018
Slidesets
A penile model in rhesus macaques to assess pharmacokinetics and characterization of HIV target cells within anatomical compartments of penile tissue- Alison Kohlmeier
Presented at:
International Workshop on HIV Transmission 2018
Slidesets
Post-exposure prophylaxis with single doses of combination EVG/COBI/FTC/TAF protect macaques against Rectal SHIV Infection- Ivana Massud
Presented at:
International Workshop on HIV Transmission 2018
Slidesets
Transmitted/Founder Virus-Like Variants are Archived in the Reservoir- Kelsie Brooks
Presented at:
International Workshop on HIV Transmission 2018
Slidesets
Genital Inflammation and PrEP effectiveness- Mckinnon Lyle ,PhD
Presented at:
International Workshop on HIV Transmission 2018
Slidesets
Comparison of genetic sequences from donor and recipient viruses from linked subtype A transmission pairs- Samantha Mcinally
Presented at:
International Workshop on HIV Transmission 2018
Slidesets
HIV, HBV and HCV infection and linkage to care in migrants: The Immigrant Take Care Advocacy (I.Ta.C.A.) experience in Palermo- Maurizio Milesi
Presented at:
International Workshop on HIV Transmission 2018
Slidesets
Where are we with long-acting PrEP?- Leah Johnson, PhD
Presented at:
International Workshop on HIV Transmission 2018
Slidesets
Where are we with long-acting treatment?- David Margolis, MD, MPH
Presented at:
International Workshop on HIV Transmission 2018
Slidesets
Heathy guts exclude oxygen- Andreas Bäumler, PhD
Presented at:
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2018